Pan-African genomics startup, 54gene has launched an initiative to facilitate translational genomics research by African scientists, it said on Tuesday. The ACTG is also expected to facilitate precision medicine across the continent as well as “harness translational genetic research across Africa” according to Founder and CEO Dr Abasi Ene-Obong. And in an inaugural effort towards achieving its mandate, the center is already funding its first study under a consortium – the Non-Communicable Diseases – Genetic Heritage Study (NCD-GHS). “Our collaboration with scientists… as a consortium, is a highly welcome initiative which we believe will be a rewarding and mutually beneficial experience for all parties,” Ene-Obong said. Founded in 2019 by Dr Ene-Obong, it aims to improve understanding of the world’s most genetically diverse population.

Source: The North Africa Journal February 05, 2020 14:48 UTC